Why the CDC’s chaos is putting American health at risk

America’s top disease control agency, the CDC, is in disarray. Hundreds of staff face repeated firings and rehirings amid lawsuits and a government shutdown. Essential departments are unmanned, vital health programs are stalled, and billions in grants are frozen. This chaos cripples public health infrastructure, erasing years of expertise and leaving the nation vulnerable. Read…

Read More

War on Big Pharma: How Donald Trump is betting on ‘biosimilar’ generic drugs

The FDA has drastically cut the time for biosimilar drug approval, aiming to halve the market entry period. This move by the Trump administration targets high biologic drug prices by fostering competition. The reform allows for analytical data to replace extensive human trials, potentially lowering costs for patients and payers while challenging Big Pharma’s market…

Read More